Welcome to CDC stacks | Recommendations for Use of a Booster Dose of inactivated vero cell culture-derived Japanese Encephalitis Vaccine --- Advisory Committee on Immunization Practices, 2012 - 7229 | Guidelines and Recommendations
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Recommendations for Use of a Booster Dose of inactivated vero cell culture-derived Japanese Encephalitis Vaccine --- Advisory Committee on Immunization Practices, 2012
  • Published Date:
    May 27, 2011
  • Status:
    current
  • Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(20):664-5.
  • Language:
    English
Filetype[PDF-1.88 MB]


  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Use of Japanese encephalitis vaccine in children : recommendations of the Advisory Committee on Immunization Practices, 2013
    Personal Author:
    Bocchini, Joseph A.; Rubin, Lorry; Fischer, Marc; Hills, Susan L.; Staples, J. Erin;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.;
    Published:
    November 15, 2013
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 62, no. 45, p. 898-900
    Description:
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include c...
    Status:
    current
    File Type:
    Filetype[PDF - 201.04 KB]
  2. Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
    Personal Author:
    Bocchini, Joseph A.; Rubin, Lorry; Fischer, Marc; Hills, Susan L.; Staples, J. Erin;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    Nov 15 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(45):898-900.
    Description:
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include c...
    File Type:
    Filetype[PDF - 127.62 KB]
  3. Japanese encephalitis vaccines; recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Fischer, Marc; Hills, Susan; Lindsey, Nicole; Staples, J. Erin;
    Corporate Author:
    United States, Advisory Committee on Immunization Practices.; Centers for Disease Control and Prevention (U.S.); National Center for Emerging and Zoonotic Infectious Diseases (proposed), Division of Vector-Borne Infectious Diseases.; National Center for Zoonotic, Vector-Borne, and Enteric Diseases (U.S.), Division of Vector-Borne Infectious Diseases., Arbovirus Diseases Branch.;
    Published:
    March 12, 2010
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-1
    Description:
    "This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recomme...
    Status:
    current
    File Type:
    Filetype[PDF - 1.55 MB]
  4. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine : Advisory Committee on Immunization Practices, 2011
    Corporate Author:
    National Center for Zoonotic, Vector-Borne and Enteric Diseases (U.S.). Division of Vector Borne Infectious Diseases.; United States. Advisory Committee on Immunization Practices.;
    Published:
    May 27, 2011
    Source:
    MMWR. Morbidity and mortality weekly report. 2011; 60(20):661-3.
    Description:
    Japanese encephalitis (JE) virus, a mosquito-borne flavivirus, is an important cause of encephalitis in Asia with a case fatality rate of 20%--30% and neurologic or psychiatric sequelae in 30%--50% of survivors (1). Travelers to JE-endemic countries ...
    Status:
    current
    File Type:
    Filetype[PDF - 1.88 MB]
  5. A Survey of US Travelers to Asia to Assess Compliance With Recommendations for the Use of Japanese Encephalitis Vaccine
    Personal Author:
    Duffy, Mark R.; Reed, Christie; Edelson, Paul J.; Blumensaadt, Sena; Crocker, Kimberly; Griggs, Anne; Biggerstaff, Brad J.; Delorey, Mark J.; Hayes, Edward B.; Fischer, Marc;
    Published:
    2013 May-Jun
    Source:
    J Travel Med. 20(3):165-170.
    Description:
    Background : Japanese encephalitis (JE) vaccine is recommended for travelers to Asia whose itineraries increase their risk of exposure to JE virus. The numbers of travelers with such itineraries and the proportion of those who receive JE vaccine are ...
    File Type:
    Filetype[PDF - 804.74 KB]